Supernus Pharmaceuticals
SUPN
#4605
Rank
C$3.37 B
Marketcap
C$57.89
Share price
0.24%
Change (1 day)
-4.21%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: C$3.37 Billion

As of September 2026 Supernus Pharmaceuticals has a market cap of C$3.37 Billion. This makes Supernus Pharmaceuticals the world's 4605th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026C$3.37 B-16.77%
2025C$4.04 B37.45%
2024C$2.94 B40.49%
2023C$2.09 B-19.85%
2022C$2.61 B32.39%
2021C$1.97 B16.53%
2020C$1.69 B4.21%
2019C$1.62 B-31.26%
2018C$2.36 B-7.82%
2017C$2.56 B52.79%
2016C$1.68 B83.99%
2015C$0.91 B120.72%
2014C$0.41 B28.98%
2013C$0.32 B46.99%
2012C$0.21 B

End of Day market cap according to different sources

On Sep 15th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

C$3.35 Billion
by Nasdaq info icon info icon
C$3.35 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$901.10 B 26,634.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$247.79 B 7,251.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.419 T 42,013.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$181.75 B 5,292.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
C$2.09 B-37.73%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
C$29.91 B 787.40%๐Ÿ‡บ๐Ÿ‡ธ USA